MT Group Blog

Filter

Autoimmune disease biospecimens

November 9, 2021
Are you studying autoimmune diseases? Perhaps you’re investigating pathologies affecting the digestive system, skin and…

Fresh tumor tissue for translational research

October 7, 2021
Do you work with fresh tumor tissue? MT Group does - we began collecting these…

Longitudinal biospecimen & data collections

August 30, 2021
The MT Group has longitudinally collected biospecimens for pharmaceutical R&D from thousands of subjects, regularly…

Rapid Enrollment of Healthy & At-Risk Populations

July 29, 2021
The  MT Group is pleased to share its strengthened blood collection capability in control populations,…

Developing Access to Liver Transplant Biospecimens

June 2, 2021
The MT Group is proud to announce it is onboarding a large academic transplant center…

MT Group Recognized as Top 10 CRO by PharmaTech Outlook

March 29, 2021
The MT Group is proud to be named a Top 10 CRO for 2021 by…

Patient-Specific Antibody Responses

May 6, 2020
Our business is to help you, the front line pharmaceutical and biotech researchers, achieve the…

Our COVID-19 Biospecimen Site Network is Live

April 27, 2020
Over the past month, we have been hard at work building a broad site network…

Unlocking COVID-19’s Secrets With Longitudinal Biospecimens

March 28, 2020
The MT Group has conducted dozens of longitudinal biospecimen collections over the past 20 years,…